Gsk Share Discussion Threads

[ny boy] 27/3/2018 09:27

Maybe this time we can finally start the journey..we have been back to the petrol station quite a few times, no more fuel can be added

Good job there is a 6% pa Divi paid quarterly better than parking cash down at el banco de ripoffo

[scottishfield] 27/3/2018 09:03

Well done Emma

[tim 3] 27/3/2018 09:02

Looks like they are buying the mark up,nice to see.

[essentialinvestor] 27/3/2018 08:58

Very welcome news.

[ygor705] 27/3/2018 08:51

Looks positive to me. Always simpler to buy out a company that you already know. As to paying for it, a movement of the fixed asset furniture looks to be on the cards although I've no idea how much Horlick is worth and what other assets may be up for grabs.

[juju44] 27/3/2018 08:23

Gap up - gaps get closed

[romeike] 27/3/2018 08:20

Suprised but delighted, Looks like GSK voluntarily added just enough to get the deal done now and remove the uncertainty, meanwhile Nov decided it needed the cash now rather than wait for more later.

[tim 3] 27/3/2018 08:12

Nice rise,now lets see if it gets sold into as has happened previously.

[pugugly] 27/3/2018 07:58

Based on opening auction bids Mr Market does not seem to like - Watch this space
Auction slightly up on previous close so appears to have been anticipated -
Other thoughts ? .

[nigelpm] 27/3/2018 07:56

Lots going on at the moment - feels like a good move this one and may well explain the Pfizer situation.

[ch1ck] 27/3/2018 07:54

The sentiment for stock at the moment is negative lets see what today's announcement brings

[thamestrader] 27/3/2018 07:35

Why do i keep reading that sterling gains are causing the FTSE (and GSK) to drop, yet i still only get $1.41/1.42 for my £. It hasn't changed significantly for weeks now.

[romeike] 26/3/2018 22:59

GSK ADR actually retraced to finish blue (only just). I do think the pound has had its little rally now and wouldn't be surprised to see it fall back quite sharply against the dollar.

[buywell3] 26/3/2018 17:49

This still looks set to retest previous lows as I have said


Meantime CWD in the USA is in 25 states and spreading , CWD is BSE equivalent



Also first case just reported in a deer in Finland

Is in Norway already and in 3 provinces of Canada

Also in South Korea


Deer can't swim across oceans ... how does it infect them ie spread

The answer looks like it is going to be from human waste ie ... muck spreading on to crops

[wuzel] 26/3/2018 16:44

So a clutch of positive reports re pipeline didn't do it, the withdrawal from the Pfizer race hasn't done it - are we really counting on a collapse of the £ to take us anywhere near last year's highs? How does this stock show any significant recovery in the short to medium term?

[bili1946] 26/3/2018 16:42

I am thinking that we need to change the header on this thread.I keep getting excited by reading "GSK- The recovery"?

[abdullla] 26/3/2018 16:20

All the recent gains are well and truely burried .

[reimomo] 26/3/2018 15:36

£ up almost a cent against the $. Must be a part of it.

[tradermichael] 26/3/2018 15:21

DJI up over 500 points, FTSE struggles to break even while GSK flounders ..... ;0)

[tradermichael] 26/3/2018 14:40

If this is the price response to no bid, one wonders what the response to a winning bid would have been ..... that surely was not "already in the price" ..... ;0),

[james dean] 26/3/2018 07:12

Glaxo CEO Dispenses Bitter Pill to Fix R&D


Emma Walmsley, the first woman to run a major pharmaceutical company, is making sweeping changes at GlaxoSmithKline, replacing nearly half the company's top 125 executives and shutting down two dozen clinical trials.

[tradermichael] 25/3/2018 10:58

As GlaxoSmithKline presses ahead with its Shingrix launch, the company picked up two important nods on Friday from regulators in Europe and Japan. These two leading drug markets are key to the shingles vaccine rollout already begun in the U.S. and Canada.
A joint venture between GSK and Daiichi Sankyo will sell the shot in Japan, Glaxo said Friday.

Along with COPD med Trelegy and HIV drug Juluca, Shingrix is among a cadre of new drugs with big sales expectations at Glaxo.

Analysts predict Shingrix will reach sales of $1.368 billion by 2022.

[alphorn] 24/3/2018 15:17

"all of which was largely ignored."

An issue with Big Pharma is that often the steady stream of good (compound) news is not incremental but replaces other drugs going off patent over that time frame. Ie. as the Pharma gets bigger it needs a massive output to stand still.
Anyone who has worked during the launch years of a Biotech will know how difficult it is to replace the original concept candidates (if they work) with new ideas to continue. Exciting though when they become those rare global successes.

[buywell3] 24/3/2018 15:12

So GSK is pulling out of buying the Health unit of Pfizer , and the share price rises in relief


What would worry me was why would anyone want to even consider buying it in the first place ?

Pfizer wouldn't be off loading it if it had any mileage left in it firstly

Secondly USA markets look set to sell off ... so the price now is way to high

Get your own house in order first ... then buy a good fit at a decent price when that is done.

This still looks set to retest previous lows IMO